9DO Stock Overview
A biotechnology company, focuses on producing nutraceutical and cannabinoid-based products. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Glow Lifetech Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.048 |
| 52 Week High | CA$0.059 |
| 52 Week Low | CA$0.012 |
| Beta | 2.56 |
| 11 Month Change | 2.13% |
| 3 Month Change | 20.00% |
| 1 Year Change | 123.26% |
| 33 Year Change | -73.18% |
| 5 Year Change | n/a |
| Change since IPO | -87.27% |
Recent News & Updates
Recent updates
Shareholder Returns
| 9DO | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0% | -1.2% | -0.02% |
| 1Y | 123.3% | -20.1% | 8.2% |
Return vs Industry: 9DO exceeded the German Pharmaceuticals industry which returned -22% over the past year.
Return vs Market: 9DO exceeded the German Market which returned 7.4% over the past year.
Price Volatility
| 9DO volatility | |
|---|---|
| 9DO Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 9DO's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: Insufficient data to determine 9DO's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | n/a | Rob Carducci | glowlifetech.com |
Glow Lifetech Corp., a biotechnology company, focuses on producing nutraceutical and cannabinoid-based products. The company engages in the commercialization of plant-based MyCell technology delivery system; water-soluble ingredients; customized blends; powder-based Capsules, and market-ready products. The company exclusive North American rights for the production, sale, and distribution rights for the certain micellization technology for cannabis and hemp derived ingredients, curcumin, vitamin K and iron.
Glow Lifetech Corp. Fundamentals Summary
| 9DO fundamental statistics | |
|---|---|
| Market cap | €4.59m |
| Earnings (TTM) | -€976.13k |
| Revenue (TTM) | €236.54k |
19.4x
P/S Ratio-4.7x
P/E RatioIs 9DO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9DO income statement (TTM) | |
|---|---|
| Revenue | CA$344.75k |
| Cost of Revenue | CA$194.76k |
| Gross Profit | CA$150.00k |
| Other Expenses | CA$1.57m |
| Earnings | -CA$1.42m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.012 |
| Gross Margin | 43.51% |
| Net Profit Margin | -412.67% |
| Debt/Equity Ratio | -655.6% |
How did 9DO perform over the long term?
See historical performance and comparison